Drugmakers Esai and Biogen notched a major breakthrough in the fight against Alzheimer’s last month, showing they were able to blunt the disease’s progression. Esai’s CEO explains what the discovery could mean for other neurological disorders https://t.co/fbZhYu959U via @BW— Bloomberg (@business) October 24, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


